Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

COMPLETED NA

Collection of Patient-Reported Symptoms and Performance Status Via the Internet

NCT00417040 · View on ClinicalTrials.gov ↗

Study Summary

This pilot clinical trial studies how well using the internet to collect symptoms and the ability to carry out daily activities works in patients with enrolled on Cancer and Leukemia Group B (CALGB) studies. A study that evaluates a patient's ability to use a clinic waiting room computer to report their symptoms and their ability to carry out daily activities may help doctors understand a patient's use of a computer to report symptoms.

Interventions

  • OTHER Questionnaire Administration
  • OTHER internet-based intervention
  • OTHER assessment of therapy complications

Study Locations (20)

California

  • East Bay Radiation Oncology Center — Castro Valley
  • Valley Medical Oncology Consultants - Castro Valley — Castro Valley
  • Valley Medical Oncology — Fremont
  • Contra Costa Regional Medical Center — Martinez
  • El Camino Hospital Cancer Center — Mountain View
  • Highland General Hospital — Oakland
  • Alta Bates Summit Medical Center - Summit Campus — Oakland
  • Bay Area Breast Surgeons, Incorporated — Oakland
  • CCOP - Bay Area Tumor Institute — Oakland
  • Larry G Strieff MD Medical Corporation — Oakland
  • Tom K Lee, Incorporated — Oakland
  • UCSF Helen Diller Family Comprehensive Cancer Center — San Francisco
  • Doctors Medical Center - San Pablo Campus — San Pablo

Illinois

  • University of Chicago Cancer Research Center — Chicago
  • Louis A. Weiss Memorial Hospital — Chicago
  • La Grange Memorial Hospital — La Grange
  • Center for Cancer Care at OSF Saint Anthony Medical Center — Rockford

Delaware

  • Tunnell Cancer Center at Beebe Medical Center — Lewes
  • CCOP - Christiana Care Health Services — Newark

Florida

  • Florida Hospital Cancer Institute at Florida Hospital Orlando — Orlando

Trial Details

FieldValue
Enrollment Target 325 participants
Start Date 2006-12
Est. Completion 2017-06-01
Phase NA

Interested in This Trial?

Always speak with your doctor before enrolling in a clinical trial.

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00417040

The ClinicalTrials.gov registry entry for NCT00417040 describes a study currently listed as completed. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 325 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 147 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.

The record links to 6 conditions, with Breast Cancer appearing as the primary indexed condition, and to 3 interventions — of which Questionnaire Administration is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.

Geographic footprint matters for practical reasons: NCT00417040 reports 20 study locations spanning 4 distinct geographic areas — top geographies include California, Illinois, Delaware. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.

Frequently Asked Questions

What is clinical trial NCT00417040 about?

NCT00417040 is a clinical study titled "Collection of Patient-Reported Symptoms and Performance Status Via the Internet". This pilot clinical trial studies how well using the internet to collect symptoms and the ability to carry out daily activities works in patients with enrolled on Cancer and Leukemia Group B (CALGB) studies. A study that evaluates a patient's ability to use a clinic waiting room computer to report t...

What is the current status of trial NCT00417040?

This trial is currently completed. It is a NA study. The enrollment target is 325 participants. The study started on 2006-12. Estimated completion is 2017-06-01.

What conditions does trial NCT00417040 study?

This clinical trial studies the following conditions: Breast Cancer, Prostate Cancer, Multiple Myeloma, Lung Cancer, Colorectal Cancer. These conditions were identified from the trial registry and reflect the primary focus areas of the research.

What interventions are being tested in trial NCT00417040?

The interventions under investigation include: Questionnaire Administration (OTHER), internet-based intervention (OTHER), assessment of therapy complications (OTHER). Each intervention is being evaluated for safety and efficacy as part of this clinical study.

Who is sponsoring clinical trial NCT00417040?

This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 147 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.

Where is trial NCT00417040 being conducted?

This trial has 20 study locations across California, Delaware, Florida, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial